Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep ...

The statement also notably included a "first-line" call out for icosapent ethyl , a novel agent approved in December 2019 for routine use in U.S. patients, including those with CAD and T2DM as ...

Compared to placebo, canagliflozin reduced the risk of the composite primary endpoint (cardiovascular mortality, nonfatal MI, nonfatal stroke) by 14% (HR: 0.86; 95% CI: 0.75-0.97).

Populations of African descent are at the forefront of the worldwide epidemic of type 2 diabetes mellitus (T2DM). Here, Anne Sumner and colleagues discuss issues related to the diagnosis and ...

Type 2 diabetes (T2DM) is a systematic multi-organ metabolic disease, which is characterized by dynamic interplay among different organs. Pancreatic islet-liver axis is closely associated with normal ...

Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). T2DM is a condition that occurs when the body develops insulin resistance and no longer responds effectively to insulin .

Out of the 100 individuals diagnosed with T2DM, ultrasonography confirmed NAFLD in 50 patients, who were categorized as Group A, while the remaining 50 patients without fatty liver comprised Group ...

CAD: More Common in Patients with T2DM and Heterozygous Familial Hypercholesterolemia? —That was the question at the center of a Chinese study that assessed patients with heterozygous familial ...

METHODOLOGY: Investigators analyzed data from clinical and laboratory tests, FibroScan, and liver ultrasonography for 154 patients (average age, 51 years; 59.7% men; 42.9% with T2DM) with MASLD in ...